Bonatti H, Steurer W, Konigsrainer A, Allerberger F, Margreiter R
Department of Transplant Surgery, University Hospital, Innsbruck, Austria.
J Chemother. 1995 Oct;7(5):442-5. doi: 10.1179/joc.1995.7.5.442.
Combined kidney-pancreas transplantation represents a widely accepted therapy for endstage diabetic nephropathy. Drainage of the pancreatic juice into the urinary bladder is the preferred surgical technique in most centers. Between January 1987 and December 1994 a total of 85 pancreas transplantations with pancreatocystostomy were performed at the Innsbruck University Hospital. In all cases a polyvinylcatheter was placed into the pancreatic duct and drained transvesically to the exterior. During several weeks after transplantation pure pancreatic juice was harvested for immunological and microbiological monitoring. Whenever a patient required antibiotic treatment, antibiotic concentrations in pancreatic juice, urine or serum were determined by means of a biological test system using Bacillus subtilis. Nine different ATCC bacterial strains were incubated in pancreatic juice collected from transplant recipients and tested for their multiplication rate. Thirteen patients acquired an infection of the pancreatic duct. Non-fermentative bacteria, gram-negative rods, Enterococcus spp. and Candida spp. were the most often isolated organisms. The in vitro tests revealed that Pseudomonas aeruginosa, Acinetobacter calcoaceticus and Escherichia coli grew very well whereas Streptococcus agalactiae was unable to multiply in pancreatic juice. Ampicillin/sulbactam was found to be excreted in high concentrations into the pancreatic juice. Many other tested antibiotics (cephalosporins, carboxypenicillins and aminoglycosides) achieved levels below the minimum inhibitory concentrations (MICs) for most bacteria. Antibiotic treatment was required for up to 5 weeks to eliminate the pathogens from the pancreas but was successful in 11 out of the 13 patients at the end. The results of this study led to changes in our antibiotic policy and helped to improve the results after pancreatic transplantation.
肾胰联合移植是终末期糖尿病肾病广泛接受的一种治疗方法。在大多数中心,将胰液引流至膀胱是首选的手术技术。1987年1月至1994年12月期间,因斯布鲁克大学医院共进行了85例胰管囊肿造口术的胰腺移植。所有病例均在胰管内放置聚乙烯导管,并经膀胱引流至体外。移植后的几周内,收集纯胰液用于免疫学和微生物学监测。每当患者需要抗生素治疗时,通过使用枯草芽孢杆菌的生物检测系统测定胰液、尿液或血清中的抗生素浓度。将9种不同的美国典型培养物保藏中心(ATCC)细菌菌株在移植受者收集的胰液中培养,并检测其繁殖率。13例患者发生了胰管感染。非发酵菌、革兰氏阴性杆菌、肠球菌属和念珠菌属是最常分离出的微生物。体外试验显示,铜绿假单胞菌、醋酸钙不动杆菌和大肠杆菌生长良好,而无乳链球菌在胰液中无法繁殖。发现氨苄西林/舒巴坦以高浓度排泄到胰液中。许多其他测试抗生素(头孢菌素、羧苄青霉素和氨基糖苷类)对大多数细菌的浓度低于最低抑菌浓度(MIC)。需要长达5周的抗生素治疗以清除胰腺中的病原体,但最终13例患者中有11例治疗成功。这项研究的结果导致了我们抗生素政策的改变,并有助于改善胰腺移植后的结果。